Insmed Inc [INSM] stock is trading at $72.65, up 3.49%. An important factor to consider is whether the stock is rising or falling in short-term value. The INSM shares have gain 12.10% over the last week, with a monthly amount drifted -7.97%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Insmed Inc [NASDAQ: INSM] stock has seen the most recent analyst activity on February 25, 2025, when RBC Capital Mkts initiated its Outperform rating and assigned the stock a price target of $100. Previously, Truist started tracking the stock with Buy rating on April 23, 2024, and set its price target to $48. On February 15, 2024, Wolfe Research initiated with a Outperform rating and assigned a price target of $42 on the stock. Wells Fargo started tracking the stock assigning a Overweight rating and suggested a price target of $55 on December 08, 2023. Guggenheim started tracking with a Buy rating for this stock on July 26, 2023, and assigned it a price target of $50. In a note dated December 09, 2022, Mizuho initiated an Buy rating and provided a target price of $28 on this stock.
Insmed Inc [INSM] stock has fluctuated between $21.92 and $84.91 over the past year. Currently, Wall Street analysts expect the stock to reach $110 within the next 12 months. Insmed Inc [NASDAQ: INSM] shares were valued at $72.65 at the most recent close of the market. An investor can expect a potential return of 51.41% based on the average INSM price forecast.
Analyzing the INSM fundamentals
Insmed Inc [NASDAQ:INSM] reported sales of 363.71M for the trailing twelve months, which represents a growth of 24.79%. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at -2.2%, Pretax Profit Margin comes in at -2.5%, and Net Profit Margin reading is -2.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.45, Equity is -10.66 and Total Capital is -0.46. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.16.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 70.78 points at the first support level, and at 68.92 for the second support level. However, for the 1st resistance point, the stock is sitting at 73.59, and for the 2nd resistance point, it is at 74.54.
Ratios To Look Out For
For context, Insmed Inc’s Current Ratio is 5.45. On the other hand, the Quick Ratio is 5.12, and the Cash Ratio is 1.87. Considering the valuation of this stock, the price to sales ratio is 36.32, the price to book ratio is 45.67.
Transactions by insiders
Recent insider trading involved Lewis William, Chair and CEO, that happened on Apr 15 ’25 when 6830.0 shares were sold. Officer, Lewis William completed a deal on Apr 15 ’25 to buy 6830.0 shares. Meanwhile, Chair and CEO Lewis William sold 6830.0 shares on Apr 01 ’25.
